Emerging Infectious Diseases (Jan 2025)

Pneumococcal Septic Arthritis among Adults, France, 2010–2018

  • Farida Hamdad,
  • Nadim El Bayeh,
  • Gabriel Auger,
  • Olivia Peuchant,
  • Frédéric Wallet,
  • Raymond Ruimy,
  • Florence Reibel,
  • Christian Martin,
  • Marie-Cécile Ploy,
  • Frédéric Robin,
  • Chrislène Laurens,
  • Philippe Lanotte,
  • Marie Kempf,
  • Jennifer Tetu,
  • Hélène Revillet,
  • Isabelle Patry,
  • Philippe Cailloux,
  • Mélissa Azouaou,
  • Emmanuelle Varon,
  • Pierre Duhaut,
  • Alain Lozniewski,
  • Vincent Cattoir

DOI
https://doi.org/10.3201/eid3101.240321
Journal volume & issue
Vol. 31, no. 1
pp. 8 – 17

Abstract

Read online

Streptococcus pneumoniae infection is considered an uncommon cause of arthritis in adults. To determine the clinical and microbiological characteristics of pneumococcal septic arthritis, we retrospectively studied a large series of cases among adult patients during the 2010–2018 conjugate vaccine era in France. We identified 110 patients (56 women, 54 men; mean age 65 years), and cases included 82 native joint infections and 28 prosthetic joint infections. Most commonly affected were the knee (50/110) and hip (25/110). Concomitant pneumococcal infections were found in 37.2% (38/102) and bacteremia in 57.3% (55/96) of patients, and underlying conditions were noted for 81.4% (83/102). Mortality rate was 9.4% (8/85). The proportion of strains not susceptible to penicillin was 29.1% (32/110). Of the 55 serotyped strains, 31 (56.4%) were covered by standard pneumococcal vaccines; however, several nonvaccine serotypes (mainly 23B, 24F, and 15A) had emerged, for which susceptibility to β-lactams was low.

Keywords